

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine catabolic process (GO:0006554) | 5.20135446 |
| 2 | lysine metabolic process (GO:0006553) | 5.20135446 |
| 3 | drug transmembrane transport (GO:0006855) | 4.84122585 |
| 4 | urate metabolic process (GO:0046415) | 4.81718798 |
| 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.51310908 |
| 6 | cell migration involved in heart development (GO:0060973) | 4.42621390 |
| 7 | valine metabolic process (GO:0006573) | 4.22036638 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 4.21299065 |
| 9 | protein heterotrimerization (GO:0070208) | 4.09374689 |
| 10 | barbed-end actin filament capping (GO:0051016) | 4.07442261 |
| 11 | homocysteine metabolic process (GO:0050667) | 4.04446604 |
| 12 | drug transport (GO:0015893) | 4.03242020 |
| 13 | fatty acid beta-oxidation (GO:0006635) | 4.01994212 |
| 14 | glyoxylate metabolic process (GO:0046487) | 3.98181497 |
| 15 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.96974568 |
| 16 | cysteine metabolic process (GO:0006534) | 3.95497602 |
| 17 | quaternary ammonium group transport (GO:0015697) | 3.89686620 |
| 18 | organic cation transport (GO:0015695) | 3.87461570 |
| 19 | tricarboxylic acid metabolic process (GO:0072350) | 3.86275919 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.82029071 |
| 21 | virion attachment to host cell (GO:0019062) | 3.81464718 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 3.81464718 |
| 23 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.81152922 |
| 24 | branched-chain amino acid metabolic process (GO:0009081) | 3.76873582 |
| 25 | response to mercury ion (GO:0046689) | 3.76122911 |
| 26 | low-density lipoprotein particle clearance (GO:0034383) | 3.74390393 |
| 27 | fatty acid oxidation (GO:0019395) | 3.69304616 |
| 28 | lipid oxidation (GO:0034440) | 3.62867956 |
| 29 | short-chain fatty acid metabolic process (GO:0046459) | 3.62558597 |
| 30 | phosphate ion transport (GO:0006817) | 3.59981897 |
| 31 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55709708 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.53614554 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 3.53614554 |
| 34 | adhesion of symbiont to host (GO:0044406) | 3.49712428 |
| 35 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.48874708 |
| 36 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.48516110 |
| 37 | collagen fibril organization (GO:0030199) | 3.47444180 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 3.43065677 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.43065677 |
| 40 | biotin metabolic process (GO:0006768) | 3.42971910 |
| 41 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.42838273 |
| 42 | amino-acid betaine transport (GO:0015838) | 3.41172738 |
| 43 | carnitine transport (GO:0015879) | 3.41172738 |
| 44 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.39580723 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.38897236 |
| 46 | aspartate family amino acid catabolic process (GO:0009068) | 3.38561911 |
| 47 | triglyceride catabolic process (GO:0019433) | 3.38117364 |
| 48 | ovulation from ovarian follicle (GO:0001542) | 3.34671139 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.32994323 |
| 50 | drug catabolic process (GO:0042737) | 3.32791776 |
| 51 | branched-chain amino acid catabolic process (GO:0009083) | 3.32383516 |
| 52 | blood vessel maturation (GO:0001955) | 3.30900960 |
| 53 | metanephric tubule development (GO:0072170) | 3.30626341 |
| 54 | metanephric nephron tubule development (GO:0072234) | 3.30626341 |
| 55 | acetyl-CoA metabolic process (GO:0006084) | 3.27889116 |
| 56 | alpha-linolenic acid metabolic process (GO:0036109) | 3.27118236 |
| 57 | endocrine hormone secretion (GO:0060986) | 3.25868528 |
| 58 | exogenous drug catabolic process (GO:0042738) | 3.24608725 |
| 59 | carnitine metabolic process (GO:0009437) | 3.24396423 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.23352871 |
| 61 | phosphate ion transmembrane transport (GO:0035435) | 3.22600688 |
| 62 | keratan sulfate catabolic process (GO:0042340) | 3.21214291 |
| 63 | aromatic amino acid family catabolic process (GO:0009074) | 3.15224059 |
| 64 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.14125849 |
| 65 | atrioventricular valve morphogenesis (GO:0003181) | 3.12109181 |
| 66 | metanephric nephron epithelium development (GO:0072243) | 3.10870376 |
| 67 | bone trabecula formation (GO:0060346) | 3.06959494 |
| 68 | neutral lipid catabolic process (GO:0046461) | 3.05893121 |
| 69 | acylglycerol catabolic process (GO:0046464) | 3.05893121 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.05616565 |
| 71 | endocardial cushion development (GO:0003197) | 3.03588944 |
| 72 | positive regulation of receptor recycling (GO:0001921) | 3.03347225 |
| 73 | positive regulation of fatty acid oxidation (GO:0046321) | 3.03315300 |
| 74 | opsonization (GO:0008228) | 3.02940223 |
| 75 | metanephric mesenchyme development (GO:0072075) | 3.01371362 |
| 76 | toxin metabolic process (GO:0009404) | 3.01349182 |
| 77 | monocarboxylic acid catabolic process (GO:0072329) | 3.01010416 |
| 78 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.00510347 |
| 79 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.96947563 |
| 80 | glomerular filtration (GO:0003094) | 2.96920251 |
| 81 | stress fiber assembly (GO:0043149) | 2.95814931 |
| 82 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.94490760 |
| 83 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.94115514 |
| 84 | apoptotic cell clearance (GO:0043277) | 2.94075523 |
| 85 | regulation of extracellular matrix disassembly (GO:0010715) | 2.94025962 |
| 86 | surfactant homeostasis (GO:0043129) | 2.93458822 |
| 87 | type B pancreatic cell proliferation (GO:0044342) | 2.90786398 |
| 88 | negative regulation of cartilage development (GO:0061037) | 2.89685314 |
| 89 | NADH metabolic process (GO:0006734) | 2.88047066 |
| 90 | cellular response to vitamin (GO:0071295) | 2.87966334 |
| 91 | indole-containing compound catabolic process (GO:0042436) | 2.86809347 |
| 92 | indolalkylamine catabolic process (GO:0046218) | 2.86809347 |
| 93 | tryptophan catabolic process (GO:0006569) | 2.86809347 |
| 94 | cell proliferation involved in metanephros development (GO:0072203) | 2.86755201 |
| 95 | renal filtration (GO:0097205) | 2.86309826 |
| 96 | fatty acid transmembrane transport (GO:1902001) | 2.84268219 |
| 97 | drug metabolic process (GO:0017144) | 2.83917931 |
| 98 | response to phenylpropanoid (GO:0080184) | 2.83575149 |
| 99 | endothelial cell chemotaxis (GO:0035767) | 2.83156123 |
| 100 | dermatan sulfate metabolic process (GO:0030205) | 2.82944946 |
| 101 | metanephric epithelium development (GO:0072207) | 2.82356881 |
| 102 | regulation of sequestering of triglyceride (GO:0010889) | 2.81822158 |
| 103 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79958107 |
| 104 | protein carboxylation (GO:0018214) | 2.79958107 |
| 105 | extracellular fibril organization (GO:0043206) | 2.79043047 |
| 106 | response to growth hormone (GO:0060416) | 2.78700702 |
| 107 | kidney mesenchyme development (GO:0072074) | 2.78515198 |
| 108 | renal absorption (GO:0070293) | 2.77393208 |
| 109 | serine family amino acid catabolic process (GO:0009071) | 2.77338712 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 2.76002333 |
| 111 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.74533761 |
| 112 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.74206299 |
| 113 | regulation of plasminogen activation (GO:0010755) | 2.72649782 |
| 114 | regulation of fatty acid oxidation (GO:0046320) | 2.71133265 |
| 115 | endodermal cell differentiation (GO:0035987) | 2.70572306 |
| 116 | cellular ketone body metabolic process (GO:0046950) | 2.69961770 |
| 117 | NADP metabolic process (GO:0006739) | 2.69826973 |
| 118 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.69551942 |
| 119 | axon extension involved in axon guidance (GO:0048846) | 2.69551942 |
| 120 | tryptophan metabolic process (GO:0006568) | 2.68900459 |
| 121 | oxaloacetate metabolic process (GO:0006107) | 2.68263801 |
| 122 | protein localization to cell surface (GO:0034394) | 2.67215090 |
| 123 | excretion (GO:0007588) | 2.66172669 |
| 124 | skin morphogenesis (GO:0043589) | 2.65985932 |
| 125 | peptide catabolic process (GO:0043171) | 2.64912632 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64706495 |
| 127 | dermatan sulfate biosynthetic process (GO:0030208) | 2.64611314 |
| 128 | carnitine transmembrane transport (GO:1902603) | 2.64433785 |
| 129 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.63884141 |
| 130 | carnitine shuttle (GO:0006853) | 2.62605756 |
| 131 | adherens junction assembly (GO:0034333) | 2.62432001 |
| 132 | sulfur compound catabolic process (GO:0044273) | 2.61882368 |
| 133 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.61779530 |
| 134 | collagen metabolic process (GO:0032963) | 2.61277833 |
| 135 | response to lead ion (GO:0010288) | 2.60138752 |
| 136 | embryo implantation (GO:0007566) | 2.59892259 |
| 137 | carboxylic acid catabolic process (GO:0046395) | 2.59605439 |
| 138 | organic acid catabolic process (GO:0016054) | 2.59605439 |
| 139 | cell-substrate junction assembly (GO:0007044) | 2.59186701 |
| 140 | kynurenine metabolic process (GO:0070189) | 2.58541193 |
| 141 | ethanol oxidation (GO:0006069) | 2.57938208 |
| 142 | extracellular matrix assembly (GO:0085029) | 2.57934344 |
| 143 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.57786540 |
| 144 | fibril organization (GO:0097435) | 2.57529514 |
| 145 | endothelial cell morphogenesis (GO:0001886) | 2.57492117 |
| 146 | basement membrane organization (GO:0071711) | 2.56720609 |
| 147 | extracellular matrix organization (GO:0030198) | 2.56328498 |
| 148 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55563532 |
| 149 | extracellular structure organization (GO:0043062) | 2.55270425 |
| 150 | tooth mineralization (GO:0034505) | 2.55014921 |
| 151 | growth hormone secretion (GO:0030252) | 2.53947030 |
| 152 | glycosaminoglycan catabolic process (GO:0006027) | 2.51297854 |
| 153 | glomerular basement membrane development (GO:0032836) | 2.50803418 |
| 154 | desmosome organization (GO:0002934) | 2.50544581 |
| 155 | positive regulation of pseudopodium assembly (GO:0031274) | 2.48778515 |
| 156 | extracellular matrix disassembly (GO:0022617) | 2.48310979 |
| 157 | cell proliferation involved in kidney development (GO:0072111) | 2.47991270 |
| 158 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.47519224 |
| 159 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.46583729 |
| 160 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.46351906 |
| 161 | epithelial cell-cell adhesion (GO:0090136) | 2.45965849 |
| 162 | smooth muscle tissue development (GO:0048745) | 2.45913689 |
| 163 | protein retention in ER lumen (GO:0006621) | 2.44044571 |
| 164 | collagen catabolic process (GO:0030574) | 2.43882918 |
| 165 | UV protection (GO:0009650) | 2.43545084 |
| 166 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.40498545 |
| 167 | multicellular organismal metabolic process (GO:0044236) | 2.39691148 |
| 168 | transcytosis (GO:0045056) | 2.38054892 |
| 169 | chondroitin sulfate catabolic process (GO:0030207) | 2.35945468 |
| 170 | cellular response to nutrient (GO:0031670) | 2.35622989 |
| 171 | cell-substrate adherens junction assembly (GO:0007045) | 2.34736954 |
| 172 | focal adhesion assembly (GO:0048041) | 2.34736954 |
| 173 | chondrocyte proliferation (GO:0035988) | 2.31801395 |
| 174 | cGMP-mediated signaling (GO:0019934) | 2.31604476 |
| 175 | negative regulation of fatty acid transport (GO:2000192) | 2.31538464 |
| 176 | regulation of smooth muscle cell migration (GO:0014910) | 2.29735918 |
| 177 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.28951733 |
| 178 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.28434051 |
| 179 | cAMP biosynthetic process (GO:0006171) | 2.27958390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.67735819 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.94960030 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.82817895 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93251804 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.90495517 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.81922597 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.29683879 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.28614182 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17314272 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.16226475 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.10389668 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.62013257 |
| 13 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.30880153 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14834085 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14354939 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11034966 |
| 17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.10742616 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05406533 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.00186507 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94453178 |
| 21 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.76107668 |
| 22 | CJUN_26792858_Chip-Seq_BT549_Human | 1.67712749 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67660315 |
| 24 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.58176017 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54848093 |
| 26 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.50189851 |
| 27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46178016 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46047900 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44750868 |
| 30 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43156995 |
| 31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43156995 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.43033724 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40770607 |
| 34 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40703243 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40636836 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39550796 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39550796 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35410800 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34867234 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33121449 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32507142 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31753107 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31363319 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29087131 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28376535 |
| 46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26600429 |
| 47 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26017077 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23704876 |
| 49 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21973448 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21289481 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21072792 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21007585 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20154251 |
| 54 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.18721575 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18441932 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17910604 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17349095 |
| 58 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14512934 |
| 59 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14502945 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13469150 |
| 61 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10691671 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09706396 |
| 63 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09636161 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09490907 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08824468 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07936240 |
| 67 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07694603 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07072009 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06801017 |
| 70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05970681 |
| 71 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04605154 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04560694 |
| 73 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04477337 |
| 74 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.04439423 |
| 75 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04216914 |
| 76 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.04079379 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03738295 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03649166 |
| 79 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03260628 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02933710 |
| 81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02894771 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02701100 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02637364 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02621822 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01378055 |
| 86 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00200256 |
| 87 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98830913 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98566316 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98214530 |
| 90 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97521858 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96763220 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95914695 |
| 93 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95368892 |
| 94 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95368892 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94189377 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93563079 |
| 97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93510685 |
| 98 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93483617 |
| 99 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91455728 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91259937 |
| 101 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91136098 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91026633 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90856057 |
| 104 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.90685151 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90214207 |
| 106 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90109101 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89697832 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88527018 |
| 109 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87853261 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87538128 |
| 111 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.87517267 |
| 112 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86342253 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85251107 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84419245 |
| 115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84152601 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.83167355 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83010982 |
| 118 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.82976756 |
| 119 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82592024 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81515680 |
| 121 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81361356 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80933487 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80316296 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79815163 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76706660 |
| 126 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76632364 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76014346 |
| 128 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.75907920 |
| 129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75883563 |
| 130 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75455041 |
| 131 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.75279304 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73607755 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71959950 |
| 134 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.71370083 |
| 135 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.70245764 |
| 136 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69979718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.64314963 |
| 2 | MP0001958_emphysema | 4.59996917 |
| 3 | MP0005275_abnormal_skin_tensile | 4.51363948 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 4.25932503 |
| 5 | MP0005360_urolithiasis | 4.05838836 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.83256551 |
| 7 | MP0003279_aneurysm | 3.35358686 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.12546824 |
| 9 | MP0009384_cardiac_valve_regurgitation | 2.92233857 |
| 10 | MP0005332_abnormal_amino_acid | 2.47548553 |
| 11 | MP0002254_reproductive_system_inflammat | 2.36855914 |
| 12 | MP0005670_abnormal_white_adipose | 2.31215480 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.17875212 |
| 14 | MP0004272_abnormal_basement_membrane | 2.06633420 |
| 15 | MP0010368_abnormal_lymphatic_system | 1.96533640 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 1.95885295 |
| 17 | MP0002295_abnormal_pulmonary_circulatio | 1.91981677 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89995334 |
| 19 | MP0003195_calcinosis | 1.88597073 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.84427434 |
| 21 | MP0005365_abnormal_bile_salt | 1.81142132 |
| 22 | MP0003252_abnormal_bile_duct | 1.72975228 |
| 23 | MP0004043_abnormal_pH_regulation | 1.69636091 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.68859213 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.67926356 |
| 26 | MP0001756_abnormal_urination | 1.63547347 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 1.53711512 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.47031782 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.46469782 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.45414613 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.43583159 |
| 32 | MP0006054_spinal_hemorrhage | 1.42104743 |
| 33 | MP0002060_abnormal_skin_morphology | 1.40644484 |
| 34 | MP0001765_abnormal_ion_homeostasis | 1.39093015 |
| 35 | MP0004130_abnormal_muscle_cell | 1.37505420 |
| 36 | MP0004858_abnormal_nervous_system | 1.36795639 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.34460780 |
| 38 | MP0005375_adipose_tissue_phenotype | 1.33803647 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.31691861 |
| 40 | MP0000751_myopathy | 1.31628663 |
| 41 | MP0002136_abnormal_kidney_physiology | 1.30681862 |
| 42 | MP0003186_abnormal_redox_activity | 1.27757956 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.27607717 |
| 44 | MP0010030_abnormal_orbit_morphology | 1.24780420 |
| 45 | MP0002168_other_aberrant_phenotype | 1.23299101 |
| 46 | MP0005508_abnormal_skeleton_morphology | 1.16720065 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.16672005 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.13186618 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.10689688 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.09262935 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08385807 |
| 52 | MP0001542_abnormal_bone_strength | 1.07645380 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.06984457 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.05691640 |
| 55 | MP0005595_abnormal_vascular_smooth | 1.04327005 |
| 56 | MP0003329_amyloid_beta_deposits | 1.02355034 |
| 57 | MP0005409_darkened_coat_color | 1.02151470 |
| 58 | MP0005023_abnormal_wound_healing | 1.01152694 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.00658539 |
| 60 | MP0000343_altered_response_to | 0.99375021 |
| 61 | MP0002971_abnormal_brown_adipose | 0.99320030 |
| 62 | MP0003011_delayed_dark_adaptation | 0.98496512 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.97697643 |
| 64 | MP0002896_abnormal_bone_mineralization | 0.97487881 |
| 65 | MP0005623_abnormal_meninges_morphology | 0.95356720 |
| 66 | MP0001849_ear_inflammation | 0.94662837 |
| 67 | MP0000681_abnormal_thyroid_gland | 0.94253236 |
| 68 | MP0003300_gastrointestinal_ulcer | 0.94165234 |
| 69 | MP0000230_abnormal_systemic_arterial | 0.93526010 |
| 70 | MP0001348_abnormal_lacrimal_gland | 0.91244777 |
| 71 | MP0003828_pulmonary_edema | 0.90837286 |
| 72 | MP0000759_abnormal_skeletal_muscle | 0.90403200 |
| 73 | MP0005388_respiratory_system_phenotype | 0.89194314 |
| 74 | MP0002133_abnormal_respiratory_system | 0.89194314 |
| 75 | MP0003950_abnormal_plasma_membrane | 0.89184545 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.89051264 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.88037614 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.86672641 |
| 79 | MP0009115_abnormal_fat_cell | 0.86228192 |
| 80 | MP0000609_abnormal_liver_physiology | 0.85821776 |
| 81 | MP0002970_abnormal_white_adipose | 0.85796743 |
| 82 | MP0004087_abnormal_muscle_fiber | 0.85374203 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.83177751 |
| 84 | MP0005165_increased_susceptibility_to | 0.81873439 |
| 85 | MP0000538_abnormal_urinary_bladder | 0.81631741 |
| 86 | MP0004883_abnormal_blood_vessel | 0.81271938 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.80206314 |
| 88 | MP0009840_abnormal_foam_cell | 0.79016458 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.78592114 |
| 90 | MP0000163_abnormal_cartilage_morphology | 0.78288364 |
| 91 | MP0001661_extended_life_span | 0.77600079 |
| 92 | MP0003045_fibrosis | 0.77340273 |
| 93 | MP0006138_congestive_heart_failure | 0.75944278 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.75198974 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.74667323 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.74426661 |
| 97 | MP0009764_decreased_sensitivity_to | 0.74420852 |
| 98 | MP0005164_abnormal_response_to | 0.74373942 |
| 99 | MP0002115_abnormal_skeleton_extremities | 0.74236726 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.74169040 |
| 101 | MP0004036_abnormal_muscle_relaxation | 0.74002614 |
| 102 | MP0001177_atelectasis | 0.73862614 |
| 103 | MP0005369_muscle_phenotype | 0.72976962 |
| 104 | MP0001614_abnormal_blood_vessel | 0.72915697 |
| 105 | MP0000249_abnormal_blood_vessel | 0.72861614 |
| 106 | MP0000749_muscle_degeneration | 0.72646630 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.71838609 |
| 108 | MP0003091_abnormal_cell_migration | 0.71660344 |
| 109 | MP0000762_abnormal_tongue_morphology | 0.70918027 |
| 110 | MP0002135_abnormal_kidney_morphology | 0.70819876 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.69799225 |
| 112 | MP0002796_impaired_skin_barrier | 0.69311950 |
| 113 | MP0001243_abnormal_dermal_layer | 0.68270815 |
| 114 | MP0005330_cardiomyopathy | 0.68140355 |
| 115 | MP0002113_abnormal_skeleton_development | 0.67606871 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.67419809 |
| 117 | MP0000858_altered_metastatic_potential | 0.67258708 |
| 118 | * MP0005390_skeleton_phenotype | 0.66758506 |
| 119 | MP0000604_amyloidosis | 0.66253104 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.66219877 |
| 121 | MP0003878_abnormal_ear_physiology | 0.66219877 |
| 122 | MP0001881_abnormal_mammary_gland | 0.64627032 |
| 123 | MP0003795_abnormal_bone_structure | 0.64365055 |
| 124 | MP0003448_altered_tumor_morphology | 0.64230697 |
| 125 | MP0004084_abnormal_cardiac_muscle | 0.64212227 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.64139679 |
| 127 | MP0000747_muscle_weakness | 0.63063389 |
| 128 | MP0001544_abnormal_cardiovascular_syste | 0.62750188 |
| 129 | MP0005385_cardiovascular_system_phenoty | 0.62750188 |
| 130 | MP0003646_muscle_fatigue | 0.62746992 |
| 131 | MP0003115_abnormal_respiratory_system | 0.62188104 |
| 132 | MP0000534_abnormal_ureter_morphology | 0.62050794 |
| 133 | MP0005501_abnormal_skin_physiology | 0.62029917 |
| 134 | * MP0001533_abnormal_skeleton_physiology | 0.61675349 |
| 135 | MP0002128_abnormal_blood_circulation | 0.61428987 |
| 136 | MP0005535_abnormal_body_temperature | 0.61413833 |
| 137 | MP0005620_abnormal_muscle_contractility | 0.60265711 |
| 138 | MP0003959_abnormal_lean_body | 0.58650346 |
| 139 | * MP0002933_joint_inflammation | 0.57980653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.24341822 |
| 2 | Premature rupture of membranes (HP:0001788) | 5.30517905 |
| 3 | Hyperglycinuria (HP:0003108) | 4.00879956 |
| 4 | Gout (HP:0001997) | 3.90303666 |
| 5 | Aortic aneurysm (HP:0004942) | 3.89523607 |
| 6 | Increased circulating renin level (HP:0000848) | 3.87983604 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 3.77896271 |
| 8 | Hypokalemic alkalosis (HP:0001949) | 3.75485831 |
| 9 | Soft skin (HP:0000977) | 3.56792442 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.53399120 |
| 11 | Broad metatarsal (HP:0001783) | 3.42332546 |
| 12 | Metabolic alkalosis (HP:0200114) | 3.41181862 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35314354 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 3.35314354 |
| 15 | Aortic dissection (HP:0002647) | 3.28587723 |
| 16 | Bladder diverticulum (HP:0000015) | 3.18313566 |
| 17 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.17638981 |
| 18 | Abnormal urine output (HP:0012590) | 3.16272488 |
| 19 | Peritonitis (HP:0002586) | 3.15724557 |
| 20 | Abnormality of chloride homeostasis (HP:0011422) | 3.15601812 |
| 21 | Abnormality of complement system (HP:0005339) | 3.14630678 |
| 22 | Renal salt wasting (HP:0000127) | 3.09466332 |
| 23 | Polyuria (HP:0000103) | 3.09124862 |
| 24 | Vascular tortuosity (HP:0004948) | 3.06821461 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.06330366 |
| 26 | Oligomenorrhea (HP:0000876) | 3.05390608 |
| 27 | Ketoacidosis (HP:0001993) | 3.04402453 |
| 28 | Proximal tubulopathy (HP:0000114) | 3.04249010 |
| 29 | Hypomagnesemia (HP:0002917) | 3.03910088 |
| 30 | Increased purine levels (HP:0004368) | 2.98038364 |
| 31 | Hyperuricemia (HP:0002149) | 2.98038364 |
| 32 | Hydroxyprolinuria (HP:0003080) | 2.98004905 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 2.98004905 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 2.97088575 |
| 35 | Abnormality of renal excretion (HP:0011036) | 2.94954772 |
| 36 | Ankle contracture (HP:0006466) | 2.92789401 |
| 37 | Ketosis (HP:0001946) | 2.89489020 |
| 38 | Pulmonary artery stenosis (HP:0004415) | 2.85945112 |
| 39 | Cardiovascular calcification (HP:0011915) | 2.85676523 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.85076877 |
| 41 | Acanthosis nigricans (HP:0000956) | 2.84918759 |
| 42 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.82489398 |
| 43 | Dilatation of the ascending aorta (HP:0005111) | 2.78385577 |
| 44 | Arterial tortuosity (HP:0005116) | 2.76836459 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.75664604 |
| 46 | Slender build (HP:0001533) | 2.75577464 |
| 47 | Cerebral aneurysm (HP:0004944) | 2.70925552 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.69625748 |
| 49 | Increased connective tissue (HP:0009025) | 2.67194148 |
| 50 | Abnormality of renin-angiotensin system (HP:0000847) | 2.64016765 |
| 51 | Hyperaldosteronism (HP:0000859) | 2.63726213 |
| 52 | Xanthomatosis (HP:0000991) | 2.62486905 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.60309526 |
| 54 | Overgrowth (HP:0001548) | 2.56550037 |
| 55 | Joint laxity (HP:0001388) | 2.55067145 |
| 56 | Abnormality of magnesium homeostasis (HP:0004921) | 2.54279653 |
| 57 | Aortic valve stenosis (HP:0001650) | 2.53514815 |
| 58 | Neonatal short-limb short stature (HP:0008921) | 2.52156768 |
| 59 | Asymmetric septal hypertrophy (HP:0001670) | 2.50904939 |
| 60 | Shallow orbits (HP:0000586) | 2.50552263 |
| 61 | Atrophic scars (HP:0001075) | 2.49703600 |
| 62 | Obstructive sleep apnea (HP:0002870) | 2.48369287 |
| 63 | Wrist flexion contracture (HP:0001239) | 2.48235972 |
| 64 | Aortic regurgitation (HP:0001659) | 2.45103278 |
| 65 | Mitral regurgitation (HP:0001653) | 2.44498768 |
| 66 | Emphysema (HP:0002097) | 2.43094468 |
| 67 | Mitral stenosis (HP:0001718) | 2.41620329 |
| 68 | Follicular hyperkeratosis (HP:0007502) | 2.41065233 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40061180 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 2.40061180 |
| 71 | Alkalosis (HP:0001948) | 2.39041777 |
| 72 | Spinal rigidity (HP:0003306) | 2.37341014 |
| 73 | Blue sclerae (HP:0000592) | 2.36930830 |
| 74 | Thin bony cortex (HP:0002753) | 2.34104775 |
| 75 | Polydipsia (HP:0001959) | 2.31645230 |
| 76 | Abnormal drinking behavior (HP:0030082) | 2.31645230 |
| 77 | Hyperammonemia (HP:0001987) | 2.30527565 |
| 78 | Biconcave vertebral bodies (HP:0004586) | 2.28184707 |
| 79 | Wormian bones (HP:0002645) | 2.27163075 |
| 80 | Tetany (HP:0001281) | 2.25129396 |
| 81 | Fragile skin (HP:0001030) | 2.24461185 |
| 82 | Coronal craniosynostosis (HP:0004440) | 2.23607447 |
| 83 | Type 1 muscle fiber predominance (HP:0003803) | 2.23441306 |
| 84 | Hyperglycinemia (HP:0002154) | 2.23223259 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.22179014 |
| 86 | Ectopia lentis (HP:0001083) | 2.20868426 |
| 87 | Cervical subluxation (HP:0003308) | 2.19944263 |
| 88 | Vascular calcification (HP:0004934) | 2.19708743 |
| 89 | Aneurysm (HP:0002617) | 2.18331594 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14888074 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.14888074 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14691951 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.14691951 |
| 94 | Ovoid vertebral bodies (HP:0003300) | 2.14627648 |
| 95 | Deep venous thrombosis (HP:0002625) | 2.12937216 |
| 96 | Spondylolisthesis (HP:0003302) | 2.12892066 |
| 97 | Mitral valve prolapse (HP:0001634) | 2.10825854 |
| 98 | Bronchomalacia (HP:0002780) | 2.10671963 |
| 99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08820583 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08820583 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08820583 |
| 102 | Nephrolithiasis (HP:0000787) | 2.07919946 |
| 103 | Polycythemia (HP:0001901) | 2.07693289 |
| 104 | Chondrocalcinosis (HP:0000934) | 2.04138336 |
| 105 | Hypokalemia (HP:0002900) | 2.03179983 |
| 106 | Hypoglycemic coma (HP:0001325) | 2.02905124 |
| 107 | Hypertriglyceridemia (HP:0002155) | 2.02426540 |
| 108 | Joint stiffness (HP:0001387) | 2.02236504 |
| 109 | Delayed CNS myelination (HP:0002188) | 2.00176453 |
| 110 | Lymphangioma (HP:0100764) | 1.99685281 |
| 111 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98598715 |
| 112 | Abnormality of the acetabulum (HP:0003170) | 1.97926965 |
| 113 | Elbow flexion contracture (HP:0002987) | 1.97759038 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.97270395 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.96782164 |
| 116 | Rectal prolapse (HP:0002035) | 1.96298192 |
| 117 | Short nail (HP:0001799) | 1.95182550 |
| 118 | Muscle fiber splitting (HP:0003555) | 1.94814079 |
| 119 | Generalized amyotrophy (HP:0003700) | 1.92359611 |
| 120 | Hyperextensible skin (HP:0000974) | 1.92346452 |
| 121 | Abnormal delivery (HP:0001787) | 1.92001001 |
| 122 | Renal tubular acidosis (HP:0001947) | 1.91581768 |
| 123 | Complement deficiency (HP:0004431) | 1.90555467 |
| 124 | Nuclear cataract (HP:0100018) | 1.90112128 |
| 125 | Hypoventilation (HP:0002791) | 1.90018368 |
| 126 | Round ear (HP:0100830) | 1.89503015 |
| 127 | Wide anterior fontanel (HP:0000260) | 1.89239988 |
| 128 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89223639 |
| 129 | Infantile muscular hypotonia (HP:0008947) | 1.88282335 |
| 130 | Coxa vara (HP:0002812) | 1.87956634 |
| 131 | Abnormality of Sharpey fibers (HP:0100685) | 1.87682368 |
| 132 | Turricephaly (HP:0000262) | 1.86837693 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 1.86811679 |
| 134 | Bowel diverticulosis (HP:0005222) | 1.86462906 |
| 135 | Genu recurvatum (HP:0002816) | 1.86323256 |
| 136 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86012207 |
| 137 | Hypercalciuria (HP:0002150) | 1.85507067 |
| 138 | Abnormality of dentin (HP:0010299) | 1.85431249 |
| 139 | Natal tooth (HP:0000695) | 1.83660715 |
| 140 | Achilles tendon contracture (HP:0001771) | 1.82778256 |
| 141 | Abnormality of potassium homeostasis (HP:0011042) | 1.82059653 |
| 142 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81311692 |
| 143 | Advanced eruption of teeth (HP:0006288) | 1.81040535 |
| 144 | Ulnar deviation of the wrist (HP:0003049) | 1.80026050 |
| 145 | Bone cyst (HP:0012062) | 1.79958502 |
| 146 | Bradycardia (HP:0001662) | 1.79250237 |
| 147 | Osteoarthritis (HP:0002758) | 1.78758965 |
| 148 | Abnormal cartilage morphology (HP:0002763) | 1.77791237 |
| 149 | Hypoplasia of the iris (HP:0007676) | 1.77733395 |
| 150 | Sparse lateral eyebrow (HP:0005338) | 1.77415985 |
| 151 | Hand muscle atrophy (HP:0009130) | 1.77115459 |
| 152 | Beaking of vertebral bodies (HP:0004568) | 1.76872002 |
| 153 | Skin nodule (HP:0200036) | 1.76747477 |
| 154 | Long toe (HP:0010511) | 1.76287709 |
| 155 | Striae distensae (HP:0001065) | 1.75401503 |
| 156 | Venous abnormality (HP:0002624) | 1.75238639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.39109977 |
| 2 | TRIB3 | 4.18029859 |
| 3 | WNK4 | 3.94241445 |
| 4 | BCKDK | 3.87629094 |
| 5 | WNK3 | 3.43604108 |
| 6 | TESK1 | 3.41376602 |
| 7 | TIE1 | 2.88579580 |
| 8 | OXSR1 | 2.83156200 |
| 9 | EPHA2 | 2.70598033 |
| 10 | TGFBR2 | 2.69008949 |
| 11 | PDK3 | 2.26820113 |
| 12 | PDK4 | 2.26820113 |
| 13 | LATS2 | 2.24443933 |
| 14 | FGFR4 | 2.13442237 |
| 15 | PDGFRA | 2.12848990 |
| 16 | DDR2 | 2.01018322 |
| 17 | SIK1 | 2.00897324 |
| 18 | MAP3K6 | 1.87727271 |
| 19 | CDC42BPA | 1.81457980 |
| 20 | TTN | 1.81214845 |
| 21 | EPHB1 | 1.77996523 |
| 22 | GRK5 | 1.74658661 |
| 23 | STK38L | 1.72382858 |
| 24 | PDK2 | 1.70377129 |
| 25 | EPHB2 | 1.69188692 |
| 26 | FER | 1.67579413 |
| 27 | CAMK1D | 1.57847639 |
| 28 | RIPK1 | 1.56508667 |
| 29 | MYLK | 1.55725582 |
| 30 | LIMK1 | 1.52464960 |
| 31 | MST1R | 1.45031247 |
| 32 | STK39 | 1.41805316 |
| 33 | PKN2 | 1.37355394 |
| 34 | EPHA3 | 1.30261428 |
| 35 | PTK2B | 1.28753832 |
| 36 | MAPK15 | 1.22463195 |
| 37 | NEK9 | 1.15472065 |
| 38 | MAP3K3 | 1.14092831 |
| 39 | CAMK1G | 1.14023584 |
| 40 | LRRK2 | 1.08872955 |
| 41 | MET | 1.06925481 |
| 42 | PTK2 | 1.06129127 |
| 43 | PTK6 | 1.04664728 |
| 44 | MAPK7 | 1.03880346 |
| 45 | GRK1 | 0.98729475 |
| 46 | PAK4 | 0.96427991 |
| 47 | RPS6KA2 | 0.95205377 |
| 48 | LMTK2 | 0.94387797 |
| 49 | PRPF4B | 0.93917590 |
| 50 | PAK3 | 0.91239973 |
| 51 | LATS1 | 0.91136752 |
| 52 | ICK | 0.89752499 |
| 53 | ARAF | 0.87542602 |
| 54 | EEF2K | 0.85516988 |
| 55 | MAP2K1 | 0.84674354 |
| 56 | WNK1 | 0.84518578 |
| 57 | PRKAA2 | 0.81561499 |
| 58 | MARK2 | 0.81163910 |
| 59 | ADRBK1 | 0.81162281 |
| 60 | ZAP70 | 0.76820264 |
| 61 | BMX | 0.76048067 |
| 62 | PINK1 | 0.75236643 |
| 63 | KDR | 0.75143488 |
| 64 | MAP2K3 | 0.74963827 |
| 65 | ABL2 | 0.74127567 |
| 66 | NTRK1 | 0.73758178 |
| 67 | GSK3A | 0.71719843 |
| 68 | CAMK1 | 0.71645927 |
| 69 | TGFBR1 | 0.70275578 |
| 70 | HIPK2 | 0.69835812 |
| 71 | SMG1 | 0.69202804 |
| 72 | PRKG2 | 0.67819236 |
| 73 | CSK | 0.67499647 |
| 74 | PRKD1 | 0.66470656 |
| 75 | MAPK4 | 0.66180875 |
| 76 | TRPM7 | 0.66178774 |
| 77 | STK38 | 0.64506898 |
| 78 | PRKCH | 0.64410663 |
| 79 | JAK1 | 0.64361059 |
| 80 | INSRR | 0.63836395 |
| 81 | NEK1 | 0.63714171 |
| 82 | PAK2 | 0.62949795 |
| 83 | PRKD2 | 0.61551930 |
| 84 | ROCK2 | 0.60811273 |
| 85 | TYK2 | 0.60285076 |
| 86 | MAP3K7 | 0.59281429 |
| 87 | FLT3 | 0.59207570 |
| 88 | PRKD3 | 0.58248864 |
| 89 | PDPK1 | 0.58000482 |
| 90 | SGK494 | 0.56455636 |
| 91 | SGK223 | 0.56455636 |
| 92 | PHKG1 | 0.55009462 |
| 93 | PHKG2 | 0.55009462 |
| 94 | FGFR3 | 0.53243203 |
| 95 | MAPK12 | 0.53014434 |
| 96 | RPS6KC1 | 0.52788249 |
| 97 | RPS6KL1 | 0.52788249 |
| 98 | DMPK | 0.51112889 |
| 99 | GRK6 | 0.49989012 |
| 100 | MAP3K13 | 0.49902386 |
| 101 | TAOK1 | 0.49398593 |
| 102 | TBK1 | 0.49125287 |
| 103 | FGFR1 | 0.48919545 |
| 104 | CAMK2G | 0.48886107 |
| 105 | PDGFRB | 0.48863917 |
| 106 | KIT | 0.48039417 |
| 107 | MAPK11 | 0.48022208 |
| 108 | ROCK1 | 0.46063406 |
| 109 | JAK2 | 0.46005768 |
| 110 | ILK | 0.43710488 |
| 111 | RPS6KA4 | 0.42338696 |
| 112 | PIM2 | 0.41665579 |
| 113 | MAPKAPK2 | 0.41607782 |
| 114 | MOS | 0.41525331 |
| 115 | MAPKAPK3 | 0.41284899 |
| 116 | IRAK1 | 0.40678027 |
| 117 | MTOR | 0.40499330 |
| 118 | PIK3CG | 0.39725818 |
| 119 | RPS6KA6 | 0.37018067 |
| 120 | PRKAA1 | 0.36497339 |
| 121 | FGFR2 | 0.36252898 |
| 122 | KSR2 | 0.34324678 |
| 123 | PRKACG | 0.34222148 |
| 124 | IGF1R | 0.33469913 |
| 125 | SRC | 0.33128184 |
| 126 | SGK3 | 0.33102358 |
| 127 | CDK6 | 0.33083990 |
| 128 | INSR | 0.32646573 |
| 129 | RET | 0.32367425 |
| 130 | JAK3 | 0.32361690 |
| 131 | DAPK3 | 0.32028813 |
| 132 | MAP2K2 | 0.31895256 |
| 133 | TAOK2 | 0.30227383 |
| 134 | MAP3K1 | 0.30189494 |
| 135 | PAK1 | 0.27794434 |
| 136 | NLK | 0.27635442 |
| 137 | MAPK3 | 0.26616355 |
| 138 | CAMK2D | 0.25435596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.12543354 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.11707653 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89949232 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67697957 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.62841599 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.60245854 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54191814 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.50672087 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.47438199 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.47396340 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36337045 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.35721556 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18473462 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11873896 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.09629669 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04844912 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.97841115 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88917100 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85239195 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.82423242 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74232841 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58598905 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.57633727 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.55444767 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.52645159 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.51782665 |
| 27 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.44720315 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.43570324 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41081759 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.39783628 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.35033019 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33418542 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32070214 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25109502 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23480194 |
| 36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22860363 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18947505 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18047909 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16750837 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12674375 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11514146 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11490064 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10637841 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09172242 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07481276 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.06789154 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.04461927 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01887866 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.99062500 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99043595 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97726167 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.96995869 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94373561 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90570688 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88963423 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88807467 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85320497 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83646397 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82361683 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82307154 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.81850648 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.81745867 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80849556 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.79409009 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79078669 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78734163 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78716562 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.78696443 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.78148561 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77878159 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.72287458 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71698024 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70714146 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70618228 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69517211 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67732954 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67693867 |
| 78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67681029 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.66270473 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66194979 |
| 81 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.64672624 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63516671 |
| 83 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63329780 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.62740353 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62279903 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61290242 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.60970714 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60752631 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.60646091 |
| 90 | Melanoma_Homo sapiens_hsa05218 | 0.59582442 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59180796 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59080676 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.58997335 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57448744 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57112299 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56460160 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55714358 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55496582 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53813738 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51626373 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51506437 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.50280740 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49998821 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48851387 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47776700 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47687017 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47273512 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.47165155 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.46763640 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46614680 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46430751 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45157353 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.45078802 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.45045880 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44165615 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43267074 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42415333 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42239098 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41839555 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39439595 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38952746 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38569401 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36513180 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35247355 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34845684 |
| 126 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34492519 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34004541 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.32614993 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32495843 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.31107295 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30731984 |
| 132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29806782 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29378070 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28642149 |
| 135 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28376556 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25443387 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24066979 |
| 138 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23086830 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19921185 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19659791 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18802851 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17588545 |
| 143 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17136408 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.14904051 |

